HAYWARD, Calif.-- (BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) today announced treatment of the first patients in its multicenter study to evaluate the safety and efficacy of its Nano-Pulse ...

Sebaceous carcinoma is an uncommon malignant neoplasm of the sebaceous glands, with an estimated incidence of 1 in 1,000,000 people per year. 1 The sebaceous glands are normally found in hair ...

Sebaceous gland carcinoma (SGC) is a rare eyelid tumour that may masquerade as a recurrent chalazion or blepharitis. 1, 2 We report a patient with SGC who had serial incision curettage for recurrent ...

HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company developing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, ...

(RTTNews) - Pulse Biosciences Inc. (PLSE), in an update to its recent FDA 510(k) submission to add the specific indication for treatment of sebaceous hyperplasia to expand the CellFX System's current ...